3rd Circ. Asked To Rethink Wellbutrin Pay-For-Delay Ruling
Wellbutrin buyers on Thursday asked the Third Circuit to reconsider an August decision siding with GlaxoSmithKline PLC in litigation accusing the company of stifling generic competition for the drug, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article